OBEZİTE VE PALYATİF BAKIM

Yazarlar

Serkan Budak
Şenay Özer
https://orcid.org/0000-0001-5888-5815

Özet

Bu bölüm, obezite ile palyatif bakım arasındaki ilişkiyi, karşılaşılan zorlukları ve çözüm önerilerini ele almaktadır. Dünya Sağlık Örgütü tarafından anormal veya aşırı yağ birikimi olarak tanımlanan obezite; diyabet, kardiyovasküler hastalıklar ve kanser gibi birçok kronik rahatsızlığa zemin hazırlayarak küresel ölçekte ciddi bir sağlık tehdidi oluşturmaktadır. Yaşam tarzı müdahaleleri, diyet, fiziksel aktivite ve davranış terapileri obezite yönetiminde temel yöntemler arasında yer almaktadır. Palyatif bakım ise yaşamı tehdit eden hastalıklarda hasta ve ailesinin yaşam kalitesini artırmayı hedefleyen multidisipliner bir yaklaşımdır. Obeziteli bireylerde yağ dokusunun fazla olması, ilaç emilimini ve semptom yönetimini olumsuz etkileyerek palyatif bakım sürecini zorlaştırmaktadır. Ayrıca bu hastalarda dış görünüş yanıltıcı olabileceğinden malnütrisyon riski göz ardı edilebilmekte; bu nedenle Beden Kitle İndeksi’nin yanı sıra antropometrik ölçümler ve biyokimyasal parametreler de değerlendirilmelidir. Morbid obezitenin palyatif bakım tanı grubuna dahil edilmesi, hastaların ve bakım verenlerin fiziksel, psikolojik, sosyal ve manevi ihtiyaçlarının karşılanması açısından büyük önem taşımaktadır.

Referanslar

Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019; 92: 6-10. Doi: 10.1016 / j.metabol.2018.09.005.

World Health Organization (2020). Obesity and overweight. (21/02/2021 tarihinde http://www.who.int/mediacentre/factsheets/fs311/en/ adresinden ulaşılmıştır).

Alamuddin N, Bakizada Z, Wadden TA. Management of obesity. Journal of Clinical Oncology. 2016; 34(35): 4295-4305. Doi: 10.1200 / JCO.2016.66.8806.

GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine. 2017; 377(1): 13-27. DOI: 10.1056/NEJMoa1614362

Singh GM, Danaei F, Farzadfar F, et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One. 2013; 8(7); e65174. https://doi.org/10.1371/journal.pone.0065174

Anstey KJ, Cherbuin N, Budge M, et al. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev. 2011; 12(5); e426-e437. https://doi.org/10.1111/j.1467-789X.2010.00825.x

Ligibel JA, Alfano CM, Hershman D, et al. Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement. J Clin Oncol. 2015; 33: 3961-3967. https://doi.org/10.1200/jco.2015.63.1440

Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Journal of the American college of cardiology. 2014; 63(25 Part B): 2985-3023.

Sacks FM, Bray GA, Carey VJ, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009; 360: 859-873. DOI: 10.1056/NEJMoa0804748

Foster GD, Wyatt HR, Hill JO, et al. Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: A randomized trial. Ann Intern Med. 2010; 153: 147-157. https://doi.org/10.7326/0003-4819-153-3-201008030-00005

Wadden TA, Webb VL, Moran CH, et al. Lifestyle modification for obesity: New developments in diet, physical activity, and behavior therapy. Circulation. 2012; 125: 1157-1170. https://doi.org/10.1161/CIRCULATIONAHA.111.039453

Barry VW, Baruth M, Beets MW, et al. Fitness vs. fatness on all-cause mortality: A meta-analysis. Prog Cardiovasc Dis. 2014; 56: 382-390. https://doi.org/10.1016/j.pcad.2013.09.002

Gaesser GA, Angadi SS, Sawyer BJ. Exercise and diet, independent of weight loss, improve cardiometabolic risk profile in overweight and obese individuals. Phys Sportsmed. 2011; 39: 87-97. https://doi.org/10.3810/psm.2011.05.1898

Watson M, Campbell R, Vallath N, et al (2019). The essential, holistic guide to palliative care. Oxford Handbook of Palliative Care. ABD: Oxford University Press.

Balducci L. Geriatric oncology, spirituality, and palliative care. Journal of pain and symptom management. 2019; 57(1): 171-175. https://doi.org/10.1016/j.jpainsymman.2018.05.009

Lam DY, Scherer JS, Brown M, et al. A conceptual framework of palliative care across the continuum of advanced kidney disease. Clinical Journal of the American Society of Nephrology. 2019; 14(4): 635-641. https://doi.org/10.2215/CJN.09330818

Nguyen V, Steiner J, Krieger E, et al. Trends in Palliative Care Use in Patients With Adult Congenital Heart Disease at the End-Of-Life. Circulation. 2019; 140(Suppl_1): A14215-A14215.

Chan KY, Chan ML. Enhanced psychosocial support as important component of neuro-palliative service. Annals of palliative medicine. 2018; 7(3): 355-358. doi: 10.21037 / apm.2017.08.19

Hofmeister M, Memedovich A, Dowsett LE, et al. Palliative care in the home: a scoping review of study quality, primary outcomes, and thematic component analysis. BMC palliative care. 2018; 17(1): 41. https://doi.org/10.1186/s12904-018-0299-z

Verberne LM, Kars MC, Schepers SA, et al. Barriers and facilitators to the implementation of a paediatric palliative care team. BMC Palliative Care. 2018; 17(1): 1-8. https://doi.org/10.1186/s12904-018-0274-8

Swami M, Case AA. Effective palliative care: what is involved?. Oncology. 2018; 32(4): 180-184.

Gündoğdu H. Evde nütrisyon desteği. İç Hastalıkları Dergisi. 2010; 17(4): 257-267.

Shatnawei A, Bharadwaj S, Konrad D, et al. Home parenteral care. Diet Nutr Crit Care. 2015; 1791-1804.

Villar-Taibo R, Martínez-Olmos MA, Bellido-Guerrero D, et al. Burden assessment in caregivers of patients with home artificial nutrition: a need and a challenge. European journal of clinical nutrition. 2017; 71(2): 192-197. https://doi.org/10.1038/ejcn.2016.239

Zaninotto P, Head J, Stamatakis E, et al. Trends in obesity among adults in England from 1993 to 2004 by age and social class and projections of prevalence to 2012. J Epidemiol Community Health. 2009; 63(2): 140–146. http://dx.doi.org/10.1136/jech.2008.077305

Hussain SS, Bloom SR. The pharmacological treatment and management of obesity. Postgrad Med. 2011; 123(1): 34-44. https://doi.org/10.3810/pgm.2011.01.2243

Nwosu AC, Raj J, Hugel, H. Palliative care and obesity: are we prepared?. Journal of palliative medicine. 2012; 15(1): 7-8. https://doi.org/10.1089/jpm.2011.0333

Gupta D. Moribund obesity as a palliative care diagnosis. J Palliat Med. 2009; 12(6): 515–516. https://doi.org/10.1089/jpm.2009.0043

Harris JA, Byhoff E, Perumalswami CR, et al. The relationship of obesity to hospice use and expenditures: a cohort study. Annals of internal medicine. 2017; 166(6): 381-389. https://doi.org/10.7326/M16-0749

Gupta D. The Relationship of Obesity to Hospice Use and Expenditures. Annals of internal medicine. 2017; 167(8): 604-605. https://doi.org/10.7326/L17-0312.

Yayınlanan

11 Mayıs 2021

Lisans

Lisans